Ignite Creation Date:
2025-12-25 @ 2:01 AM
Ignite Modification Date:
2026-01-04 @ 3:53 PM
Study NCT ID:
NCT00593060
Status:
COMPLETED
Last Update Posted:
2023-05-24
First Post:
2007-12-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Temsirolimus (CCI-770, Torisel) Combined With Cetuximab in Cetuximab-Refractory Colorectal Cancer
Sponsor:
Jeffrey W. Clark, MD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-11-01
Start Date Type:
ACTUAL
Primary Completion Date:
2009-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-11
Completion Date Type:
ACTUAL
First Submit Date:
2007-12-28
First Submit QC Date:
None
Study First Post Date:
2008-01-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-23
Last Update Post Date:
2023-05-24
Last Update Post Date Type:
ACTUAL